Respiratory Review of 2013: Pulmonary Thromboembolism / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 89-94, 2013.
Article
Dans Anglais
| WPRIM
| ID: wpr-74266
ABSTRACT
Pulmonary embolism (PE), which can originate as a consequence of deep vein thrombosis (DVT), is the most frequent and potentially fatal venous thromboembolic event. Despite the fact that the incidence of venous thromboembolism (VTE) in Asians is lower than that in the Western populations, a recent epidemiologic study demonstrates an increasing incidence of VTE in the Korean population. Anticoagulants, including low molecular weight heparin (LMWH) and vitamin K antagonist (VKAs), have been the main treatments for PE, however, recently new oral anticoagulants (NOACs) were introduced. We will review how well patients with PE can be managed with the existing anticoagulants and NOACs along with the time span of treatment, which still pose some challenges for clinicians.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Embolie pulmonaire
/
Vitamine K
/
Incidence
/
Héparine bas poids moléculaire
/
Thrombose veineuse
/
Asiatiques
/
Thromboembolisme veineux
/
Anticoagulants
Type d'étude:
Etude d'incidence
/
Étude pronostique
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Tuberculosis and Respiratory Diseases
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS